Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual IFN-γ/hypoxia priming enhances immunosuppression of mesenchymal stromal cells through regulatory proteins and metabolic mechanisms
Holly Wobma, Mariko Kanai, P. Stephen, et al.
Journal of Immunology and Regenerative Medicine (2018) Vol. 1, pp. 45-56
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
Nádia de Cássia Noronha, Amanda Mizukami, Carolina Caliári-Oliveira, et al.
Stem Cell Research & Therapy (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 487
The influence of hypoxia and IFN-γ on the proteome and metabolome of therapeutic mesenchymal stem cells
Holly Wobma, Manuel A. Tamargo, Shahar Goeta, et al.
Biomaterials (2018) Vol. 167, pp. 226-234
Open Access | Times Cited: 88
Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis
Madina Sarsenova, Assel Issabekova, Saule Abisheva, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11592-11592
Open Access | Times Cited: 75
Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells
Madina Sarsenova, Yevgeniy Kim, Kamila Raziyeva, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 64
Pretreated Mesenchymal Stem Cells and Their Secretome: Enhanced Immunotherapeutic Strategies
Yuran Su, Chenyu Xu, Wen Cheng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1277-1277
Open Access | Times Cited: 35
Immunological priming of mesenchymal stromal/stem cells and their extracellular vesicles augments their therapeutic benefits in experimental graft-versus-host disease via engagement of PD-1 ligands
Alexander Hackel, Sebastián Vollmer, Kirsten Bruderek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Impacts of priming on distinct immunosuppressive mechanisms of mesenchymal stromal cells under translationally relevant conditions
Nick Herger, Irina Heggli, Tamara Mengis, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
High throughput screening of mesenchymal stromal cell morphological response to inflammatory signals for bioreactor-based manufacturing of extracellular vesicles that modulate microglia
Andrew M. Larey, Thomas M. Spoerer, Kanupriya R. Daga, et al.
Bioactive Materials (2024) Vol. 37, pp. 153-171
Open Access | Times Cited: 7
Human OX40L–CAR-T regs target activated antigen-presenting cells and control T cell alloreactivity
Xianliang Rui, Francesca Alvarez‐Calderon, Holly Wobma, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 769
Closed Access | Times Cited: 6
HIF1α‐dependent metabolic reprogramming governs mesenchymal stem/stromal cell immunoregulatory functions
Rafael Contreras‐López, Roberto Elizondo‐Vega, M.J. Paredes, et al.
The FASEB Journal (2020) Vol. 34, Iss. 6, pp. 8250-8264
Closed Access | Times Cited: 49
Mesenchymal Stem Cells and Atopic Dermatitis: A Review
Sérgio Ricardo Teixeira Daltro, Cássio Santana Meira, Ivanilson Pimenta Santos, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 40
Hypoxia preconditioning elicit differential response in tissue-specific MSCs via immunomodulation and exosomal secretion
Suchi Gupta, Sonali Rawat, V. Krishnakumar, et al.
Cell and Tissue Research (2022) Vol. 388, Iss. 3, pp. 535-548
Closed Access | Times Cited: 27
Lung Fibrosis Is Improved by Extracellular Vesicles from IFNγ-Primed Mesenchymal Stromal Cells in Murine Systemic Sclerosis
Pauline Rozier, Marie Maumus, A. Maria, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2727-2727
Open Access | Times Cited: 27
Putative critical quality attribute matrix identifies mesenchymal stromal cells with potent immunomodulatory and angiogenic “fitness” ranges in response to culture process parameters
Kevin P. Robb, Julie Audet, Rajiv Gandhi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Therapeutic Efficacy of Interferon-Gamma and Hypoxia-Primed Mesenchymal Stromal Cells and Their Extracellular Vesicles: Underlying Mechanisms and Potentials in Clinical Translation
Yu Ling Tan, Maimonah Eissa Al-Masawa, Sue Ping Eng, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1369-1369
Open Access | Times Cited: 3
Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma
Soumya R. Mohapatra, Ahmed Sadik, Lars‐Oliver Tykocinski, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 28
Differential effects of the cystic fibrosis lung inflammatory environment on mesenchymal stromal cells
Soraia C. Abreu, Thomas H. Hampton, Evan T. Hoffman, et al.
AJP Lung Cellular and Molecular Physiology (2020) Vol. 319, Iss. 6, pp. L908-L925
Open Access | Times Cited: 24
The ATP synthase inhibition induces an AMPK-dependent glycolytic switch of mesenchymal stem cells that enhances their immunotherapeutic potential
Rafael Contreras‐López, Roberto Elizondo‐Vega, Noymar Luque‐Campos, et al.
Theranostics (2020) Vol. 11, Iss. 1, pp. 445-460
Open Access | Times Cited: 24
Role of Hypoxia in the Interferon Response
Esther Arnaiz, Adrian L. Harris
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Expansion of human bone marrow-derived mesenchymal stromal cells with enhanced immunomodulatory properties
Shu Hui Neo, Zhisheng Her, Rashidah Othman, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Pediatric Mesenchymal Stem Cells Exhibit Immunomodulatory Properties Toward Allogeneic T and B Cells Under Inflammatory Conditions
Virginia Palomares Cabeza, Martin J. Hoogduijn, Rens Kraaijeveld, et al.
Frontiers in Bioengineering and Biotechnology (2019) Vol. 7
Open Access | Times Cited: 23
Functional heterogeneity of IFN-γ–licensed mesenchymal stromal cell immunosuppressive capacity on biomaterials
Brian J. Kwee, Johnny Lam, Adovi Akue, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 35
Open Access | Times Cited: 20
The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells
Haiping He, Atsuko Takahashi, Takeo Mukai, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 19
Cytokine Activation Reveals Tissue-Imprinted Gene Profiles of Mesenchymal Stromal Cells
Danielle M. Wiese, Catherine A. Wood, B. Ford, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid Arthritis
Vitaly Chasov, Irina Ganeeva, Ekaterina Zmievskaya, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1282-1282
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top